Position in ALLO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,532,884
+$7,485,048 QoQ
Shares Held
3,621,579
+18372.7% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#26
of 209 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. ALLO ranks #29 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,089,376 | $81,136,724 | |
| 2 | INSM |
INSMED Inc
|
689,981 | $73,565,774 | |
| 3 | EXEL |
Exelixis, Inc.
|
929,242 | $50,560,057 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
84,634 | $45,444,226 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
178,491 | $43,689,242 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
498,655 | $40,645,369 | |
| 7 | ABVX |
Abivax S.A.
|
270,612 | $36,061,755 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
622,603 | $34,205,808 |
All Filings in ALLO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,532,884 | 3,621,579 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $47,836 | 19,605 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $99,668 | 72,751 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $164,338 | 132,531 | Shares | Defined | 2025-11-14 | |
| 2023-12-31 | $755,418 | 235,333 | Shares | Defined | 2024-02-09 | |
| 2023-03-31 | $514,609 | 104,172 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $1,190,797 | 110,259 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $159,271 | 10,675 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $1,271,435 | 36,018 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||